Automate CFR 11 approvals for TOSCA and qTest
TL;DR
CFR 11-compliant middleware for QA/Testing Managers and Compliance Officers in pharma/biotech (100+ employees) that auto-syncs TR/ER from TOSCA to qTest, AI-routes approvals with auto-escalation, and logs all actions in a tamper-proof audit trail so they can reduce approval cycles from days to hours and eliminate manual compliance errors
Target Audience
QA/Testing Managers and Compliance Officers in pharma, medical devices, and biotech companies (100+ employees) using TOSCA for test automation and qTest for test management.
The Problem
Problem Context
Teams using TOSCA for test automation and qTest for test management face a critical gap: TOSCA lacks CFR 11 compliance, forcing them to manually extract test results (TR) and error reports (ER), upload them to qTest, and seek approvals from multiple stakeholders. This breaks regulated workflows and creates compliance risks.
Pain Points
Users waste 10+ hours per week on manual data transfers between TOSCA and qTest. They avoid customizing TOSCA (a COTS system) because it voids support and creates maintenance risks. Approval delays slow down drug/device approvals, and manual processes introduce errors that fail audits. Current workarounds (e.g., spreadsheets, email chains) are unreliable and don’t scale.
Impact
Delays in compliance approvals can cost $100K–$1M+ per day in lost revenue for pharma/biotech companies. Manual errors risk regulatory penalties or rejected submissions. Teams spend unnecessary time on repetitive tasks instead of higher-value work. Compliance officers face constant stress over audit readiness and approval tracking.
Urgency
This problem cannot be ignored because CFR 11 violations can halt entire product launches. Regulatory deadlines are fixed, and missed approvals directly impact revenue. Teams need a solution that works today—not in six months—because manual processes are already failing under current workloads.
Target Audience
QA/Testing Managers, Compliance Officers, and Regulatory Affairs Specialists in pharma, medical devices, and biotech. These roles are common in mid-market to enterprise companies (100+ employees) with regulated testing workflows. Similar pain points exist in other CFR 11/Annex 11-compliant industries, such as clinical research organizations (CROs).
Proposed AI Solution
Solution Approach
A lightweight middleware tool that sits between TOSCA and qTest, automatically extracting TR/ER from TOSCA, routing them to qTest for approvals, and logging all actions for CFR 11 compliance. The tool uses AI to assist with approval workflows (e.g., auto-escalation, anomaly detection) while avoiding any customization of TOSCA. It’s designed for zero-touch setup via API keys and config files.
Key Features
- AI-Assisted Approval Routing: Uses machine learning to suggest approvers, detect anomalies in test results, and auto-escalate stalled approvals—reducing bottlenecks.
- Compliance Audit Trail: Logs every action (who approved what, when, and why) in a tamper-proof format for regulators.
- Configurable Workflows: Lets users define custom approval chains (e.g., 'If test fails, notify QA Manager and Compliance Officer').
User Experience
Users set up the tool once via API keys and a config file. From then on, test results flow automatically from TOSCA to qTest, with approvals routed to the right people. The AI flags potential issues (e.g., missing signatures, incomplete data) before they become problems. Compliance officers get real-time dashboards showing approval statuses and audit trails, so they can focus on high-risk items instead of manual tracking.
Differentiation
Unlike TOSCA or qTest (which don’t natively support CFR 11 workflows), this tool is built specifically for the gap between them. It avoids customizing TOSCA—a key user requirement—while adding AI features that vendors don’t offer. Competitors either require expensive consulting or don’t handle the TOSCA-qTest integration. The tool’s defensibility comes from its proprietary AI models trained on CFR 11 compliance patterns.
Scalability
The product scales with the user’s needs: add more seats as the team grows, or upgrade to modules like advanced AI anomaly detection or integrations with other compliance tools (e.g., Veeva). Enterprise plans offer custom SLAs and white-labeling for large pharma companies. The middleware architecture ensures it works regardless of how much data flows between TOSCA and qTest.
Expected Impact
Teams save 10+ hours per week on manual work and eliminate compliance risks from manual errors. Approval cycles shrink from days to hours, accelerating drug/device launches. Audit readiness improves because all actions are logged automatically. The tool pays for itself within weeks by reducing consulting costs and avoiding regulatory penalties.